Zobrazeno 1 - 10
of 4 906
pro vyhledávání: '"Erythropoietin receptor"'
Publikováno v:
Heliyon, Vol 10, Iss 3, Pp e25051- (2024)
Background: Over the past decades, accumulating research on erythropoietin (EPO) and its receptor (EPOR) has revealed various neuroprotective actions and upregulation in hypoxic conditions. To our knowledge, EPOR protein levels in the hippocampus and
Externí odkaz:
https://doaj.org/article/db7d562a8b054a5cb911d9dca4a5e81e
Autor:
A. P. Lykov
Publikováno v:
Сибирский научный медицинский журнал, Vol 43, Iss 2, Pp 29-39 (2023)
Erythropoietin (EPO) exerts its effect on erythroid lineage cells through interaction with the EPO receptor (EPOR), the so-called canonical pathway, and through a complex consisting of EPOR and a common cytokine receptor beta subunit (CD131) – a n
Externí odkaz:
https://doaj.org/article/dd4ebf574d294f92b0d8512c60cec735
Autor:
Felix Marius Bläsius, Johannes Greven, Weijun Guo, Eftychios Bolierakis, Zhizhen He, Cavan Lübke, Tim-Philipp Simon, Frank Hildebrand, Klemens Horst
Publikováno v:
European Journal of Medical Research, Vol 28, Iss 1, Pp 1-10 (2023)
Abstract Little is known about the impact of multiple trauma (MT)-related systemic hypoxia on osseous protein concentration of the hypoxia transcriptome. To shed light on this issue, we investigated erythropoietin (Epo), erythropoietin receptor (EpoR
Externí odkaz:
https://doaj.org/article/9a6925dde0a0475495cf59f2fc09ddf5
Autor:
Kazuki Omata, Ikki Nomura, Akito Hirata, Yuka Yonezuka, Hiroshi Muto, Ryo Kuriki, Kirin Jimbo, Koujin Ogasa, Takashi Kato
Publikováno v:
Biology Open, Vol 12, Iss 8 (2023)
Externí odkaz:
https://doaj.org/article/8f03de7a673f4222b6f94e27f4991b8f
Autor:
Hyeok-Jin Kwon, MD, Jung-Hwan Kim, MD, Dong-Wha Yoo, MD, Tae-Hoon Kim, MD, Jung-Ho Yoon, MD, Ki-Ho Kim, MD, PhD
Publikováno v:
JAAD Case Reports, Vol 16, Iss , Pp 101-104 (2021)
Externí odkaz:
https://doaj.org/article/c13a62d55e21444fbd0fa85e9d279029
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Yuki Kawai, Yoshiyuki Toya, Hiromichi Wakui, Tetsuya Fujikawa, Eiko Ueda, Kengo Azushima, Sho Kinguchi, Hiroshi Mitsuhashi, Tomoyuki Kawano, Tadashi Kuji, Satoshi Yamaguchi, Toshimasa Ohnishi, Kouichi Tamura
Publikováno v:
Journal of Pharmacological Sciences, Vol 147, Iss 1, Pp 118-125 (2021)
Our previous randomized controlled trial comparing the total dose of weekly versus biweekly continuous erythropoietin receptor activator (CERA) therapy to maintain optimal hemoglobin (Hb) levels showed no significant differences between the two thera
Externí odkaz:
https://doaj.org/article/bc8b5ab08cbb441db2084058f0dfc4de
Autor:
Mostafa A. Aboouf, Franco Guscetti, Nadine von Büren, Julia Armbruster, Hyrije Ademi, Maja Ruetten, Florinda Meléndez-Rodríguez, Thomas Rülicke, Alexander Seymer, Robert A. Jacobs, Edith M. Schneider Gasser, Julian Aragones, Drorit Neumann, Max Gassmann, Markus Thiersch
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Erythropoietin receptor (EPOR) is widely expressed in healthy and malignant tissues. In certain malignancies, EPOR stimulates tumor growth. In healthy tissues, EPOR controls processes other than erythropoiesis, including mitochondrial metabolism. We
Externí odkaz:
https://doaj.org/article/310af4056b6044878b44d59abc419570
Autor:
Zuzana Tóthová, Martina Šemeláková, Katarína Bhide, Mangesh Bhide, Andrej Kováč, Petra Majerová, Monika Kvaková, Jana Štofilová, Zuzana Solárová, Peter Solár
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 10, p 8482 (2023)
The erythropoietin receptor (EPOR) is a transmembrane type I receptor with an essential role in the proliferation and differentiation of erythroid progenitors. Besides its function during erythropoiesis, EPOR is expressed and has protective effect in
Externí odkaz:
https://doaj.org/article/88a435e5e0c34f05bc1fa1cda85257d3
Publikováno v:
Pharmaceuticals, Vol 16, Iss 4, p 610 (2023)
Neuroprotective drugs to protect the brain against cerebral ischemia and reperfusion (I/R) injury are urgently needed. Mammalian cell-produced recombinant human erythropoietin (rhuEPOM) has been demonstrated to have excellent neuroprotective function
Externí odkaz:
https://doaj.org/article/bd627d199349486982072b72704b4b42